Antifungal potential, mechanism of action, and toxicity of 1,4-naphthoquinone derivatives.

2,3-DBNQ antifungal potential cytotoxicity fungal membrane permeability naphthoquinone derivatives

Journal

European journal of microbiology & immunology
ISSN: 2062-509X
Titre abrégé: Eur J Microbiol Immunol (Bp)
Pays: Hungary
ID NLM: 101569896

Informations de publication

Date de publication:
23 Aug 2024
Historique:
received: 20 06 2024
accepted: 06 08 2024
medline: 23 8 2024
pubmed: 23 8 2024
entrez: 23 8 2024
Statut: aheadofprint

Résumé

The rising prevalence of fungal infections and challenges such as adverse effects and resistance against existing antifungal agents have driven the exploration of new antifungal substances. We specifically investigated naphthoquinones, known for their broad biological activities and promising antifungal capabilities. It specifically examined the effects of a particular naphthoquinone on the cellular components of Candida albicans ATCC 60193. The study also assessed cytotoxicity in MRC-5 cells, Artemia salina, and the seeds of tomatoes and arugula. Among four tested naphthoquinones, 2,3-DBNQ (2,3-dibromonaphthalene-1,4-dione) was identified as highly effective, showing potent antifungal activity at concentrations between 1.56 and 6.25 μg mL-1. However, its cytotoxicity in MRC-5 cells (IC50 = 15.44 µM), complete mortality in A. salina at 50 μg mL-1, and significant seed germination inhibition suggest limitations for its clinical use. The findings indicate that primary antifungal mechanism of 2,3-DBNQ might involve disrupting fungal membrane permeability, which leads to increased nucleotide leakage. This insight underscores the need for further research to enhance the selectivity and safety of naphthoquinones for potential therapeutic applications.

Sections du résumé

Background UNASSIGNED
The rising prevalence of fungal infections and challenges such as adverse effects and resistance against existing antifungal agents have driven the exploration of new antifungal substances.
Methods UNASSIGNED
We specifically investigated naphthoquinones, known for their broad biological activities and promising antifungal capabilities. It specifically examined the effects of a particular naphthoquinone on the cellular components of Candida albicans ATCC 60193. The study also assessed cytotoxicity in MRC-5 cells, Artemia salina, and the seeds of tomatoes and arugula.
Results UNASSIGNED
Among four tested naphthoquinones, 2,3-DBNQ (2,3-dibromonaphthalene-1,4-dione) was identified as highly effective, showing potent antifungal activity at concentrations between 1.56 and 6.25 μg mL-1. However, its cytotoxicity in MRC-5 cells (IC50 = 15.44 µM), complete mortality in A. salina at 50 μg mL-1, and significant seed germination inhibition suggest limitations for its clinical use.
Conclusions UNASSIGNED
The findings indicate that primary antifungal mechanism of 2,3-DBNQ might involve disrupting fungal membrane permeability, which leads to increased nucleotide leakage. This insight underscores the need for further research to enhance the selectivity and safety of naphthoquinones for potential therapeutic applications.

Identifiants

pubmed: 39178045
doi: 10.1556/1886.2024.00072
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Juan Diego Ribeiro de Almeida (JDR)

1Postgraduate Program in Biotechnology and Natural Resources of the Amazon, Higher School of Health Sciences, Amazonas State University (UEA), Manaus, Amazonas, Brazil.
2Mycology Laboratory, National Institute for Amazonian Research (INPA), Manaus, Amazonas, Brazil.

Raissa Sayumy Kataki Fonseca (RSK)

1Postgraduate Program in Biotechnology and Natural Resources of the Amazon, Higher School of Health Sciences, Amazonas State University (UEA), Manaus, Amazonas, Brazil.
2Mycology Laboratory, National Institute for Amazonian Research (INPA), Manaus, Amazonas, Brazil.

Naira Sulany Oliveira de Sousa (NSO)

2Mycology Laboratory, National Institute for Amazonian Research (INPA), Manaus, Amazonas, Brazil.

Ana Cláudia Alves Cortez (ACA)

2Mycology Laboratory, National Institute for Amazonian Research (INPA), Manaus, Amazonas, Brazil.

Emerson Silva Lima (ES)

3Faculty of Pharmaceutical Sciences, Federal University of Amazonas (UFAM), Manaus, Amazonas, Brazil.

Juliana Gomes de Souza Oliveira (JG)

4Collection of Microorganisms of Medical Interest, National Institute for Amazonian Research (INPA), Manaus, Amazonas, Brazil.

Érica Simplício de Souza (ÉS)

1Postgraduate Program in Biotechnology and Natural Resources of the Amazon, Higher School of Health Sciences, Amazonas State University (UEA), Manaus, Amazonas, Brazil.
5Higher School of Technology, Amazonas State University (UEA), Manaus, Amazonas, Brazil.

Hagen Frickmann (H)

6Institute for Medical Microbiology, Virology and Hygiene, University Medicine Rostock, Rostock, Germany.
7Department of Microbiology and Hospital Hygiene, Bundeswehr Hospital, Germany.

João Vicente Braga de Souza (JVB)

2Mycology Laboratory, National Institute for Amazonian Research (INPA), Manaus, Amazonas, Brazil.

Classifications MeSH